Your browser doesn't support javascript.
loading
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age.
Carlos, Josefina Cadorna; Tadesse, Birkneh Tilahun; Borja-Tabora, Charissa; Alberto, Edison; Ylade, Michelle C; Sil, Arijit; Kim, Deok Ryun; Ahn, Hyeon Seon; Yang, Jae Seung; Lee, Ji Yeon; Kim, Min Soo; Park, Jiwook; Kwon, Soo-Young; Kim, Hun; Yang, Seon-Young; Ryu, Ji-Hwa; Park, Hokeun; Shin, Jong-Hoon; Lee, Yoonyeong; Kim, Jerome H; Mojares, Zenaida Reynoso; Wartel, T Anh; Sahastrabuddhe, Sushant.
Afiliação
  • Carlos JC; University of the East-Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines.
  • Tadesse BT; International Vaccine Institute, Seoul, Republic of Korea.
  • Borja-Tabora C; Asian Hospital and Medical Center, Muntinlupa, Metro Manila, Philippines.
  • Alberto E; Medical Research Unit, Tropical Disease Foundation, Inc., Makati City, Metro Manila, Philippines.
  • Ylade MC; University of the Philippines Manila-National Institutes of Health, Ermita, Manila, Philippines.
  • Sil A; International Vaccine Institute, Seoul, Republic of Korea.
  • Kim DR; International Vaccine Institute, Seoul, Republic of Korea.
  • Ahn HS; International Vaccine Institute, Seoul, Republic of Korea.
  • Yang JS; International Vaccine Institute, Seoul, Republic of Korea.
  • Lee JY; International Vaccine Institute, Seoul, Republic of Korea.
  • Kim MS; International Vaccine Institute, Seoul, Republic of Korea.
  • Park J; International Vaccine Institute, Seoul, Republic of Korea.
  • Kwon SY; International Vaccine Institute, Seoul, Republic of Korea.
  • Kim H; SK bioscience, Seongmam-si, Seoul, Republic of Korea.
  • Yang SY; SK bioscience, Seongmam-si, Seoul, Republic of Korea.
  • Ryu JH; SK bioscience, Seongmam-si, Seoul, Republic of Korea.
  • Park H; SK bioscience, Seongmam-si, Seoul, Republic of Korea.
  • Shin JH; SK bioscience, Seongmam-si, Seoul, Republic of Korea.
  • Lee Y; SK bioscience, Seongmam-si, Seoul, Republic of Korea.
  • Kim JH; International Vaccine Institute, Seoul, Republic of Korea.
  • Mojares ZR; International Vaccine Institute, Seoul, Republic of Korea.
  • Wartel TA; International Vaccine Institute, Seoul, Republic of Korea.
  • Sahastrabuddhe S; International Vaccine Institute, Seoul, Republic of Korea.
Lancet Reg Health West Pac ; 24: 100484, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35664443
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article